Back to Search
Start Over
CRT-400.26 Transfemoral Aortic Valve Implantation in Patients With Symptomatic Severe Aortic Stenosis With the Repositionable Lotus Valve: Results From a High Volume Center
- Source :
- JACC: Cardiovascular Interventions. 9(4)
- Publication Year :
- 2016
- Publisher :
- Elsevier BV, 2016.
-
Abstract
- The Lotus valve (Boston Scientific Corporation) is designed to reduce the risk for residual paravalvular aortic regurgitation and can be easily repositioned. The study evaluates the procedural and 30-day results for the 23, 25 and 27mm Lotus valve in patients undergoing transfemoral aortic valve
Details
- ISSN :
- 19368798
- Volume :
- 9
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- JACC: Cardiovascular Interventions
- Accession number :
- edsair.doi.dedup.....477230511d2faf2100b1ec1e06a894d3
- Full Text :
- https://doi.org/10.1016/j.jcin.2015.12.249